What is the recommended starting dose, titration schedule, monitoring parameters, and contraindications for captopril in an adult with hypertension or heart failure (including diabetic nephropathy)?

Captopril Dosing and Management

Start captopril at 6.25 mg three times daily in heart failure patients (especially those on diuretics or with volume depletion) or 25 mg twice to three times daily in hypertension, titrate upward every 2 weeks to target doses of 50-100 mg three times daily for heart failure or 50 mg three times daily for hypertension, while monitoring blood pressure, renal function (creatinine, potassium), and watching for hypotension, hyperkalemia, and cough. 1

Starting Doses by Indication

Heart Failure

• High-risk patients (on vigorous diuretics, hyponatremic, hypovolemic, or low blood pressure): Start at 6.25 mg three times daily 1, 2
• Standard patients: Start at 25 mg three times daily 1, 2
• Must be initiated under close medical supervision 1

Hypertension

• Standard starting dose: 25 mg twice or three times daily 1
• Take one hour before meals 1

Post-Myocardial Infarction with LV Dysfunction

• Initiate as early as 3 days post-MI
• Single test dose of 6.25 mg, then 12.5 mg three times daily
• Increase to 25 mg three times daily over several days
• Target: 50 mg three times daily over several weeks 1

Diabetic Nephropathy

• 25 mg three times daily for long-term use 1

Titration Schedule

For Heart Failure:

• Start low (6.25-25 mg three times daily)
• Double dose at minimum 2-week intervals 2
• After reaching 50 mg three times daily, delay further increases for at least 2 weeks to assess response 1
• Target: 50-100 mg three times daily 2, 1
• Maximum: 450 mg/day (never exceed) 1

For Hypertension:

• If inadequate response after 1-2 weeks at 25 mg twice/three times daily, increase to 50 mg twice/three times daily 1
• If still inadequate, add thiazide diuretic (e.g., hydrochlorothiazide 25 mg daily) 1
• Can further increase to 100 mg twice/three times daily, then 150 mg twice/three times daily if needed 1
• Usual effective range: 25-150 mg twice/three times daily 1

Critical Monitoring Parameters

Before Initiation

• Baseline creatinine and potassium
• Blood pressure (sitting and standing)
• Volume status
• Current diuretic use

During Titration (Check at Each Dose Increase)

• Blood pressure: Monitor for symptomatic hypotension
• Renal function: Creatinine and BUN
• Potassium: Watch for hyperkalemia
• Timing: Check within 1-2 weeks of each dose change 2

Acceptable Changes

• Creatinine increase up to 50% above baseline OR up to 3 mg/dL (266 μmol/L), whichever is greater, is acceptable 2
• Potassium up to 5.5-6.0 mmol/L is generally acceptable 2
• Asymptomatic hypotension does not require intervention 2

Contraindications and Cautions

Seek Specialist Advice Before Starting:

• Creatinine > 2.5 mg/dL (> 221 μmol/L) 2
• Hyperkalemia > 5.0 mmol/L 2
• Systolic BP < 90 mmHg (symptomatic or severe asymptomatic hypotension) 2

Absolute Contraindications (from general knowledge):

• History of angioedema with ACE inhibitors
• Pregnancy
• Bilateral renal artery stenosis

Problem-Solving Common Issues

Symptomatic Hypotension

• Review and reduce/stop non-essential vasodilators (calcium channel blockers, nitrates) 2
• If no signs of congestion, reduce diuretic dose 2
• Do NOT stop captopril for asymptomatic low BP 2

Worsening Renal Function

• Stop nephrotoxic drugs (NSAIDs) 2
• Stop potassium supplements and potassium-sparing diuretics (amiloride, triamterene) 2
• If no congestion, reduce diuretic dose 2
• If creatinine or potassium rise excessively despite these measures, reduce captopril dose 2

Cough

• Very common; rarely requires discontinuation 2
• First exclude pulmonary edema 2
• Only switch to angiotensin receptor blocker if cough is severe (e.g., preventing sleep) AND proven due to ACE inhibitor by withdrawal/rechallenge 2

Renal Impairment Dosing

• Reduce initial dose in significant renal impairment 1
• Use smaller increments for titration 1
• Titrate slowly (1-2 week intervals) 1
• Use loop diuretics (furosemide) rather than thiazides in severe renal impairment 1
• After achieving therapeutic effect, back-titrate to find minimal effective dose 1

Key Clinical Pearls

• Some ACE inhibitor is better than no ACE inhibitor—aim for target dose but accept highest tolerated dose 2
• Higher doses reduce death/hospitalization more than lower doses in heart failure (ATLAS trial) 2
• Always use with diuretic and digoxin in heart failure 1
• Beta-blockers can be added but effects are less than additive 1
• First-dose hypotension risk is highest in volume-depleted patients—consider holding diuretic dose before initiation 1